EACTS - European Association for Cardio-Thoracic Surgery’s Post

Now deployed at the Clinical Research Center of Hôpital Fondation Adolphe de Rothschild in Paris, real-time Doppler holography of the retina is set to become a new standard for non-invasive monitoring of quantitative retinal and choroidal hemodynamic biomarkers. 👁 ❤️ The ‘Holodoppler’ programme (public funding #France2030) is a consortium comprising Lumibird Medical - Quantel Medical, Ellex & Optotek,Hôpital Fondation Adolphe de Rothschild, Hôpital national des Quinze-Vingts , and ESPCI Paris - PSL. 🎯 The aim is to develop a non-invasive medical device capable of quantitatively measuring ocular blood flow. This optical doppler using digital holography will make it possible to quantify ocular haemodynamics and improve diagnosis and monitoring of #glaucoma and #hypertension.

📆 Join us and Dr. Claudio Iovino (MD, PhD) in our In-sight Webinar Series—a recurring appointment with the latest insight on posterior segment care. Dr. Iovino shares two major case reports from LightWave I, our multi-centric clinical trial focused on the application of LM® LLLT (PBM) technology in the management of AREDS 2 & 3 dry Age-related Macular Degeneration (dAMD) with eye-light®. The case reports, recently accepted for publication at ARVO 2024, present two impressive cases of patients with dry AMD and non-neovascular AMD who benefitted from LM® LLLT therapy. In the keynote Dr. Iovino will discuss: ◽ How dAMD will increasingly impact modern society ◽ How LM® LLLT photobiomodulation technology works, and the promise it holds ◽ LightWave I Clinical Trial: what it is, what we're doing, where we're going ◽ Case Report 1: AREDS 3 dry AMD ◽ Case Report 2: Non-neovascular AMD w/ PED and Subretinal Fluid ◽ LightWave II Clinical Trials: how to apply The event will be followed by a Live Q&A session with our Medical Affairs Team. Register now for groundbreaking AMD insights with Dr. Claudio Iovino! Secure your spot here 👇 https://lnkd.in/dXYr9r5Z #espansionegroup #scienceonward #lightmodulation #PBM #dAMD

🔬 Electrophysiology in Action: A Precise Approach to Treating Atypical Atrial Flutter ⚡ I’d like to share this video showcasing the power of advanced technology in tackling complex arrhythmias. This case involves an atypical atrial flutter, where electroanatomic mapping is crucial for identifying the reentry circuits and key areas for ablation. With cutting-edge systems like Carto by Biosense Webster , we can accurately target the affected zones and perform safer, more effective ablations. Precision in treating atypical atrial flutter is essential to minimize recurrences and improve long-term outcomes. Johnson & Johnson MedTech | Electrophysiology

Learn how EIBIR can work for you 👇

THIS IS BIG! Further evidence that #photoncounting CT changes clinical pathways in coronary artery disease. 49% of patients in the study were classified to a lower CAD-RADS score (and likely a more conservative treatment option) when scanned with NAEOTOM Alpha compared to conventional CT. We are getting ready to make this pathway change available to more caregivers and their patients around the world. Milan Vecsey-Nagy U. Joseph Schoepf MD, FACR, FAHA, FNASCI, FSCBT-MR, FSCCT Emese Zsarnoczay Nicola Fink Giuseppe Tremamunno Chiara Gnasso Moritz Halfmann Bálint Szilveszter Pál Maurovich-Horvat Ismail Mikdat Kabakus Akos Varga-Szemes Tilman Emrich, MD, EBCR, FSCMR Society of Cardiovascular Computed Tomography MUSC Cardiovascular Imaging University Medical Center Mainz American Heart Association

We’ve compiled a selection of academic papers that align with key themes covered at this year’s Annual Radiotherapy Conference. This includes this systematic review on RISR interventions, to access it and other research visit ow.ly/yIHn50TCZqM #ARC2024

Phakic Intraocular Lenses (Phakic IOLs) are specialized lenses implanted in the eye to correct vision in individuals with extremely high refractive errors, thin cornea, particularly those who are not ideal candidates for laser eye surgeries like LASIK or PRK. Unlike standard intraocular lenses used after cataract surgery, phakic IOLs are placed in eyes that still have their natural lenses (hence the term "phakic," which refers to the presence of the natural lens). Procedure: - Phakic IOL implantation is an outpatient procedure performed under local anesthesia. - A small incision is made in the cornea to insert the lens, which is folded and then unfolded inside the eye. - It is a reversible procedure, meaning the lens can be removed or replaced if needed. Advantages: - Reversibility: Unlike LASIK, which permanently reshapes the cornea, phakic IOLs can be removed or exchanged if necessary. -Preservation of the cornea: The cornea is left untouched, which is beneficial for patients with thin or irregular corneas. I am happy to tell you about this topic in Barcelona

New review on the European Heart Journal 💻 The HeartSim research team at PrediSurge, in partnership with the University of Ottawa Heart Institute and Hôpital Saint Joseph of Marseille, has contributed a significant study to the European Heart Journal Cardiovascular Imaging, demonstrating the precision of our PlanOp® Structural Heart software in simulating Mitral Valve interventions. This work, which reflects an impact factor of 6.3, marks an important advancement in the field of cardiovascular care. Our research focused on a case study involving a 73-year-old patient, successfully treated with a Mitraclip XTL® for severe mitral regurgitation. The application of our finite element prototype software accurately predicted the outcomes of this intervention, offering a promising tool for future cardiovascular treatments. This publication underscores the potential of digital simulation technologies to improve patient outcomes and supports our ongoing commitment to innovation in healthcare: https://bit.ly/3U9ILhW 🌐 #cardiovascular #care #digital #solutions #planop #clinicians #technology #digitaltwin

A First Step into bringing Novel US FDA Breakthrough technology to the US , A Giant Leap of Hope & Promise for US based Patients suffering from complex Coronary occlusive vascular disease . Concept Medical is proud to announce commencement of its Pivotal US FDA Investigational Devise Exemption Study for the treatment of Instent Restenosis with Magic Touch SCB - The World's 1st CE commercialized Novel Sirolimus Drug Coated Balloon , offering a safer and effective alternative for treatment of complex coronary disease such as InStent Restenosis . We are thankful to Dr Ajay Kirtane , Dr Azeem Latib , the principal investigators of the study and all the US study investigators supporting the enrollment and treatment in this pivotal multi- centered Randomised clinical trial. With Over 23K patients touched with Its clinical trial program with results that are altering standards of care and shaping the future of percutaneous treatment of occlusive vascular disease with over 180 K patients treated in real world setting with its solutions accross vascular disease , this milestone is indeed an important step to extend these proven technlogies to ailing patients in the US # Worlds 1st CE commercialized Sirolimus DCB #US FDA Breakthrough Devices # Largest and Longest Studied Clinical trial program touching over 23 K patients # over 180 K patients treated - Confidence Inspired by Real World Use.

👏 Exciting news – results of the PVISION study have been published in EP Europace!    PVISION, a prospective multicenter study, assessed PVI Analyzer, our automated AI-based algorithm. Designed to accurately determine vein isolation status, this algorithm underwent rigorous review against expert opinion in real-world clinical settings.   𝘼𝙣𝙙 𝙩𝙝𝙚 𝙧𝙚𝙨𝙪𝙡𝙩𝙨: The study validated our automated algorithm using machine learning to assess the isolation status of pulmonary veins in patients undergoing PVI with different ablation modalities. 🎯 The algorithm reached an AUC of 92% with both sensitivity and specificity exceeding the primary study endpoints.    Scroll below for highlights and check out the article here: https://lnkd.in/gn6JwZkx   #cardiology #clinicaldata #medtech #epeeps Jan De Pooter, MD, PhD, Liesbeth Timmers, Serge Boveda, Stephane combes, S Knecht,  Alexandre Almorad, Carlo de Asmundis, Mattias Duytschaever